Allstate price target raised to $235 from $230 at UBS

UBS raised the firm’s price target on Allstate (ALL) to $235 from $230 and keeps a Buy rating on the shares. P&C Insurance stocks under coverage were down 4% in 2Q25, on average, reflecting less favorable fundamentals and a shift from defensive stocks to more economically sensitive stocks, the analyst tells investors in a research note. UBS favors Personal lines insurers into 2Q25 results where margins remain attractive.